FRANK KONDOS: Open Payments
NPI 1952415366 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,512 in 177 payments from 23 companies in 2025. Trend: 2023 $3,448 · 2024 $3,952 · 2025 $3,512
Food & beverage: $3,512
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $477 |
| PFIZER INC. | 18 | $368 |
| ABBVIE INC. | 24 | $318 |
| Novo Nordisk Inc | 10 | $287 |
| Abbott Laboratories | 9 | $281 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $271 |
| Lundbeck LLC | 14 | $253 |
| Otsuka America Pharmaceutical, Inc. | 11 | $242 |
| Corium, LLC | 8 | $200 |
| Lilly USA, LLC | 11 | $187 |
Products named: REXULTI, JARDIANCE, FREESTYLE LIBRE 3, AIRSUPRA, Azstarys, Wegovy, NURTEC ODT, FARXIGA.
Industry payments across OK — which companies pay providers there.
